Targeting SREBP-1-driven Lipid Metabolism to Treat Cancer
2014 · Current Pharmaceutical Design · 307 citations
https://doi.org/10.2174/13816128113199990486
D
Deliang Guo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
171
Papers
8.1K
Citations
38
h-index
62
i10-index
Deliang Guo is an academic researcher from University of Ottawa. The author has contributed to research in topics: Cancer, Lipids, and Metabolism & Cholesterol and Lipid Metabolism & Cancer, Hypoxia, and Metabolism. The author has an h-index of 38, co-authored 146 publications.
ORCID: 0000-0002-8359-390XPapers by this author
worksDifferential sensitivity of melanoma cell lines with BRAF V600E mutation to the specific Raf inhibitor PLX4032
2010 · Journal of Translational Medicine · 224 citations
https://doi.org/10.1186/1479-5876-8-39
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
2013 · Cell Metabolism · 163 citations
https://doi.org/10.1016/j.cmet.2013.04.013
Lipid Droplets Maintain Energy Homeostasis and Glioblastoma Growth via Autophagic Release of Stored Fatty Acids
2020 · iScience · 98 citations
https://doi.org/10.1016/j.isci.2020.101569
Combination therapy with vemurafenib (PLX4032/RG7204) and metformin in melanoma cell lines with distinct driver mutations
2011 · Journal of Translational Medicine · 96 citations
https://doi.org/10.1186/1479-5876-9-76
Feedback Loop Regulation of SCAP/SREBP-1 by miR-29 Modulates EGFR Signaling-Driven Glioblastoma Growth
2016 · Cell Reports · 76 citations
https://doi.org/10.1016/j.celrep.2016.07.017
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat